库尔库明和梅尔法兰的联合治疗诱导细胞循环停止和乳腺癌细胞MDA-MB-231中的亡
Carlos Luan A Passos1, Renata Madureira Polinati1, Christian Ferreira1
1Functional Foods Laboratory, Nutrition Institute, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
库尔库明和梅尔法兰联合治疗显示出显著的抗乳腺癌效应. 这种联合治疗有效地降低了癌细胞活力,并在MDA-MB-231细胞中诱导了亡.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 生物化学 生化学
背景情况:
- 乳腺癌是全球癌症死亡的主要原因之一.
- 饮食中的生物活性化合物,就像香料中的生物活性化合物一样,显示出化学预防和化疗潜力.
- 黄素表现出抗炎和抗癌的特性.
研究的目的:
- 为了研究黄素和梅尔法兰对MDA-MB-231乳腺癌细胞的联合作用.
- 评估这种联合治疗在降低癌细胞活力和诱导细胞死亡方面的有效性.
- 探索组合治疗效果背后的分子机制.
主要方法:
- 培养的MDA-MB-231乳腺癌细胞被用黄素和梅尔法兰治疗.
- 细胞活力在24小时和48小时后进行评估.
- 分析了殖民地形成单位,ROS水平,细胞周期进展,细胞亡和酶活性.
主要成果:
- 结合黄素和梅尔法兰 (CURC/MEL) 显著降低了乳腺癌细胞活力.
- CURC/MEL减少了殖民地形成单位和增加了活性氧物种 (ROS) 水平.
- 组合疗法改变了细胞周期,诱导了细胞亡,并上调了caspases-3, -7和 -9.
结论:
- 与黄素和梅尔法兰联合治疗显示出强大的抗乳腺癌活性.
- 这种组合疗法代表了乳腺癌治疗的有希望的策略.
- 需要对黄素和梅尔法兰联合治疗进行进一步的临床研究.
更多相关视频
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
13:38Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
Published on: January 18, 2017
相关概念视频
Inhibition of Cdk Activity
Targeted Cancer Therapies
There are several types of targeted therapies against...
Drugs that Stabilize Microtubules
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Drugs that Destabilize Microtubules
Mitogens and the Cell Cycle
